ATE319819T1 - Humane hirn-spezifische carboxypeptidase b - Google Patents

Humane hirn-spezifische carboxypeptidase b

Info

Publication number
ATE319819T1
ATE319819T1 AT00922936T AT00922936T ATE319819T1 AT E319819 T1 ATE319819 T1 AT E319819T1 AT 00922936 T AT00922936 T AT 00922936T AT 00922936 T AT00922936 T AT 00922936T AT E319819 T1 ATE319819 T1 AT E319819T1
Authority
AT
Austria
Prior art keywords
human brain
specific carboxypeptidase
carboxypeptidase
specific
gene
Prior art date
Application number
AT00922936T
Other languages
English (en)
Inventor
Akira Matsumoto
Original Assignee
Akira Matsumoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akira Matsumoto filed Critical Akira Matsumoto
Application granted granted Critical
Publication of ATE319819T1 publication Critical patent/ATE319819T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4709Amyloid plaque core protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hydrogenated Pyridines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00922936T 1999-04-30 2000-05-01 Humane hirn-spezifische carboxypeptidase b ATE319819T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12516999 1999-04-30

Publications (1)

Publication Number Publication Date
ATE319819T1 true ATE319819T1 (de) 2006-03-15

Family

ID=14903603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00922936T ATE319819T1 (de) 1999-04-30 2000-05-01 Humane hirn-spezifische carboxypeptidase b

Country Status (8)

Country Link
US (3) US7060266B1 (de)
EP (1) EP1179588B9 (de)
JP (1) JP4579422B2 (de)
AT (1) ATE319819T1 (de)
AU (1) AU4316600A (de)
DE (1) DE60026501T2 (de)
ES (1) ES2260011T3 (de)
WO (1) WO2000066717A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000066717A1 (fr) 1999-04-30 2000-11-09 Akira Matsumoto Carboxypeptidase b du cerveau humain
US6455294B1 (en) * 2001-03-21 2002-09-24 Applera Corporation Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
US7291587B2 (en) 2001-11-09 2007-11-06 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
US7091331B2 (en) 2002-03-04 2006-08-15 Bristol-Myers Squibb Company Nucleic acid molecules and polypeptides encoding baboon TAFI
EP1380290A1 (de) 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-Beta-Strukturweg und seine therapeutische Relevanz
EP1794294B1 (de) * 2004-09-27 2011-07-20 Sanofi-Aventis Deutschland GmbH Rekombinante carboxypeptidase b
US7807789B2 (en) * 2004-12-21 2010-10-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
US8114832B2 (en) 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
CA2615028A1 (en) 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Cross-.beta. structure binding compounds
KR100851035B1 (ko) * 2005-08-23 2008-08-11 대한민국 GCP-Ⅱ를 유효성분으로 함유하는 β-아밀로이드의 뇌내축적 예방 및 치료용 약학적 조성물과 치료제 스크리닝용조성물 및 이를 이용한 스크리닝 방법
JP5775356B2 (ja) * 2011-05-09 2015-09-09 松本 明 神経保護作用を有するペプチド及びこれを含む薬剤
US8877446B2 (en) * 2011-08-26 2014-11-04 Korea Research Institute Of Bioscience And Biotechnology Method for detecting protein-protein interactions in cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
US5985562A (en) * 1997-06-03 1999-11-16 Schering Aktiengesellschaft Method of detecting thrombotic disease risk associated with plasma carboxypeptidase B polymorphisms
WO2000066717A1 (fr) 1999-04-30 2000-11-09 Akira Matsumoto Carboxypeptidase b du cerveau humain

Also Published As

Publication number Publication date
EP1179588B1 (de) 2006-03-08
EP1179588B9 (de) 2006-07-19
WO2000066717A1 (fr) 2000-11-09
EP1179588A4 (de) 2004-04-07
ES2260011T3 (es) 2006-11-01
AU4316600A (en) 2000-11-17
US20060024760A1 (en) 2006-02-02
DE60026501D1 (en) 2006-05-04
DE60026501T2 (de) 2006-08-10
US7524934B2 (en) 2009-04-28
US7972771B2 (en) 2011-07-05
JP4579422B2 (ja) 2010-11-10
EP1179588A1 (de) 2002-02-13
US7060266B1 (en) 2006-06-13
US20100021951A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
DE60142614D1 (de) Inität
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
FI963101A7 (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoo n, joissa seerumin interleukiini-6-taso on kohonnut
DK1521831T3 (da) Transgent dyr der udtrykker trunkeret alzheimers tauprotein
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
DE68911120D1 (de) Knochenraspel.
EE05492B1 (et) Farmatseutilised kompositsioonid, nendega seotud meetodid ja nende kasutamine amloidogeensete haiguste korral
NO995458L (no) Humane 12-lignende reseptorproteiner, beslektede reagenser og metoder
ES2153671T3 (es) Peptidos neuroactivos.
DK1887014T3 (da) Humane Toll-homologer
DE60026501D1 (en) Humane hirn-spezifische carboxypeptidase b
ATE295423T1 (de) Phosphodiesterase 8
DE69943022D1 (de) Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor
ATE254476T1 (de) 88kda tumorgener wachstumsfaktor und antagonisten
DE69634918D1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
AU2001232275A1 (en) Novel collagen-like protein clac, precursor thereof and genes encoding the same
EP1023906A4 (de) Verstärker für antikörper gegen lymphoiden tumor
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
DE60113968D1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
ATE291586T1 (de) Humanes antibiotisches protein
DE69734890D1 (de) Rdgb-proteine
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
EP1191096A4 (de) Neues protein und dessen dns
DE60042056D1 (de) Menschliche Carnosinase 2
ATE336503T1 (de) Cyclophilin als allergen identifiziert

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties